Lv5
1180 积分 2022-09-06 加入
Treatment of membranous nephropathy: a novel approach?
14天前
已完结
The Diagnosis Accuracy of PLA2R-AB in the Diagnosis of Idiopathic Membranous Nephropathy: A Meta-Analysis
3个月前
已完结
Coffee consumption, health benefits and side effects: a narrative review and update for dietitians and nutritionists
3个月前
已完结
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
4个月前
已完结
Comparison of obinutuzumab and rituximab for treating primary membranous nephropathy
4个月前
已关闭
Obinutuzumab as Initial or Second-line Therapy in Patients With Primary Membranous Nephropathy
4个月前
已完结
Comparison of obinutuzumab and rituximab for treating primary membranous nephropathy
5个月前
已关闭
Obinutuzumab may be an effective and safe option for adult minimal change disease and focal segmental glomerulosclerosis patients after multitarget therapy including rituximab
5个月前
已关闭
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
5个月前
已完结
Obinutuzumab may be an effective and safe option for adult minimal change disease and focal segmental glomerulosclerosis patients after multitarget therapy including rituximab
5个月前
已关闭
皖公网安备34019202002308
